EPS Creative Health Technology Group (3860) Fundamentals 2026 — Revenue Analysis | SniperIQ
EPS Creative Health Technology Group (3860) is a HK-listed Consumer Cyclical company in Apparel - Retail with a market capitalization of HK
EPS Creative Health Technology Group (3860) has a market capitalization of approximately HK
EPS Creative Health Technology Group's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 3.0x. Valuation multiples are best compared with Consumer Cyclical sector peers rather than read in isolation.
EPS Creative Health Technology Group runs a net profit margin of -3.0%, a gross margin of 16.4%, and an operating margin of 0.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
EPS Creative Health Technology Group reported revenue of HK$458M for fiscal year 2025, with net income of -HK
EPS Creative Health Technology Group offers a trailing dividend yield of about 1.7%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
EPS Creative Health Technology Group carries a debt-to-equity ratio of 0.04x and a current ratio of 1.83x, with a market beta of -0.02. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For EPS Creative Health Technology Group (3860) the key facts are: market cap HK
Get EPS Creative Health Technology Group's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.